Table 2.
Clinical symptoms and vital signs at admission of the neonates with COVID-19
| Total (n = 187) |
Severe group (n = 84) |
Nonsevere group (n = 103) |
P | |
|---|---|---|---|---|
| Clinical Symptoms | ||||
| Fever, n (%) | 141(75.4) | 62(73.8) | 79(76.7) | 0.648 |
| Highest temperature, mean ± SD | 38.2 ± 0.5 | 38.2 ± 0.5 | 38 ± 0.4 | 0.083 |
| Respiratory symptoms, n (%) | 134(71.7) | 72(85.7) | 62(60.2) | 0.000* |
| Tachypnea, n (%) | 16(8.6) | 13(15.5) | 3(2.9) | 0.002* |
| Cough, n (%) | 97(51.9) | 56(66.7) | 41(39.8) | 0.000* |
| Nasal congestion, n (%) | 81(43.3) | 40(47.6) | 41(39.8) | 0.283 |
| Nasal discharge, n (%) | 26(13.9) | 13(15.5) | 13(12.6) | 0.575 |
| Gastro-intestinal symptoms, n (%) | 69(36.9) | 30(35.7) | 39(37.9) | 0.762 |
| Vomiting, n (%) | 6(3.20) | 2(2.4) | 4(3.9) | 0.557 |
| Diarrhea, n (%) | 9(4.8) | 4(4.8) | 5(4.9) | 0.977 |
| Anorexia, n (%) | 57(30.5) | 25(29.8) | 32(31.1) | 0.847 |
| Neural symptoms, n (%) | 26(13.9) | 12(14.3) | 14(13.6) | 0.892 |
| Lethargy, n (%) | 25(13.4) | 12(14.3) | 13(12.6) | 0.739 |
| Seizure, n (%) | 2(1.1) | 0 | 2(1.9) | 0.121 |
| Vital signs at admission | ||||
| Heart rate, bpm, mean ± SD | 141 ± 12 | 143 ± 12 | 143 ± 13 | 0.881 |
| Respiratory rate, bpm, mean ± SD | 44 ± 7 | 44 ± 7 | 45 ± 7 | 0.366 |
| Systolic blood pressure, mmHg, mean ± SD | 75 ± 8 | 76 ± 8 | 75 ± 8 | 0.112 |
| Diastolic blood pressure, mmHg, median (IQR) | 40(35–45) | 42(35–46) | 39(35–43) | 0.127 |
| SpO2, %, mean ± SD | 97 ± 7 | 96 ± 12 | 98 ± 1 | 0.155 |
| Temperature, ℃, mean ± SD | 37.2 ± 0.6 | 37.3 ± 0.6 | 37.3 ± 0.6 | 0.998 |